457 related articles for article (PubMed ID: 32103345)
21. CGRP receptor antagonism and migraine therapy.
Edvinsson L; Warfvinge K
Curr Protein Pept Sci; 2013 Aug; 14(5):386-92. PubMed ID: 23745702
[TBL] [Abstract][Full Text] [Related]
22. Methylprednisolone blocks interleukin 1 beta induced calcitonin gene related peptide release in trigeminal ganglia cells.
Neeb L; Hellen P; Hoffmann J; Dirnagl U; Reuter U
J Headache Pain; 2016; 17():19. PubMed ID: 26931452
[TBL] [Abstract][Full Text] [Related]
23. Developments in targeting calcitonin gene-related peptide.
Alabbad S; Figueredo N; Yuan H; Silberstein S
Expert Rev Neurother; 2024 May; 24(5):477-485. PubMed ID: 38557226
[TBL] [Abstract][Full Text] [Related]
24. Expression and function of calcitonin gene-related peptide (CGRP) receptors in trigeminal ganglia of R192Q Cacna1a knock-in mice.
Vilotti S; Vana N; Van den Maagdenberg AM; Nistri A
Neurosci Lett; 2016 May; 620():104-10. PubMed ID: 27021026
[TBL] [Abstract][Full Text] [Related]
25. Calcitonin gene-related peptide antagonists as treatments of migraine and other primary headaches.
Goadsby PJ
Drugs; 2005; 65(18):2557-67. PubMed ID: 16392873
[TBL] [Abstract][Full Text] [Related]
26. Calcitonin gene-related peptide antagonism and cluster headache: an emerging new treatment.
Ashina H; Newman L; Ashina S
Neurol Sci; 2017 Dec; 38(12):2089-2093. PubMed ID: 28856479
[TBL] [Abstract][Full Text] [Related]
27. Effect of Infusion of Calcitonin Gene-Related Peptide on Cluster Headache Attacks: A Randomized Clinical Trial.
Vollesen ALH; Snoer A; Beske RP; Guo S; Hoffmann J; Jensen RH; Ashina M
JAMA Neurol; 2018 Oct; 75(10):1187-1197. PubMed ID: 29987329
[TBL] [Abstract][Full Text] [Related]
28. Calcitonin Gene-Related Peptide-Targeted Therapies for Migraine and Cluster Headache: A Review.
Schuster NM; Rapoport AM
Clin Neuropharmacol; 2017; 40(4):169-174. PubMed ID: 28644160
[TBL] [Abstract][Full Text] [Related]
29. Trigeminovascular calcitonin gene-related peptide function in Cacna1a R192Q-mutated knock-in mice.
Chan KY; Labastida-Ramírez A; Ramírez-Rosas MB; Labruijere S; Garrelds IM; Danser AH; van den Maagdenberg AM; MaassenVanDenBrink A
J Cereb Blood Flow Metab; 2019 Apr; 39(4):718-729. PubMed ID: 28792272
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of the non-peptide CGRP receptor antagonist BIBN4096BS in blocking CGRP-induced dilations in human and bovine cerebral arteries: potential implications in acute migraine treatment.
Moreno MJ; Abounader R; Hébert E; Doods H; Hamel E
Neuropharmacology; 2002 Mar; 42(4):568-76. PubMed ID: 11955527
[TBL] [Abstract][Full Text] [Related]
31. Sex differences in behavior and expression of CGRP-related genes in a rodent model of chronic migraine.
Stucky NL; Gregory E; Winter MK; He YY; Hamilton ES; McCarson KE; Berman NE
Headache; 2011 May; 51(5):674-92. PubMed ID: 21521205
[TBL] [Abstract][Full Text] [Related]
32. Recognizing the role of CGRP and CGRP receptors in migraine and its treatment.
Edvinsson L; Warfvinge K
Cephalalgia; 2019 Mar; 39(3):366-373. PubMed ID: 29020807
[TBL] [Abstract][Full Text] [Related]
33. Migraine and cluster headache - the common link.
Vollesen AL; Benemei S; Cortese F; Labastida-Ramírez A; Marchese F; Pellesi L; Romoli M; Ashina M; Lampl C;
J Headache Pain; 2018 Sep; 19(1):89. PubMed ID: 30242519
[TBL] [Abstract][Full Text] [Related]
34. Changes in calcitonin gene-related peptide (CGRP) receptor component and nitric oxide receptor (sGC) immunoreactivity in rat trigeminal ganglion following glyceroltrinitrate pretreatment.
Seiler K; Nusser JI; Lennerz JK; Neuhuber WL; Messlinger K
J Headache Pain; 2013 Sep; 14(1):74. PubMed ID: 24004534
[TBL] [Abstract][Full Text] [Related]
35. CGRP mechanism antagonists and migraine management.
Karsan N; Goadsby PJ
Curr Neurol Neurosci Rep; 2015 May; 15(5):25. PubMed ID: 25790955
[TBL] [Abstract][Full Text] [Related]
36. CGRP receptors in the control of pain and inflammation.
Benemei S; Nicoletti P; Capone JG; Geppetti P
Curr Opin Pharmacol; 2009 Feb; 9(1):9-14. PubMed ID: 19157980
[TBL] [Abstract][Full Text] [Related]
37. Elevated levels of calcitonin gene-related peptide in upper spinal cord promotes sensitization of primary trigeminal nociceptive neurons.
Cornelison LE; Hawkins JL; Durham PL
Neuroscience; 2016 Dec; 339():491-501. PubMed ID: 27746346
[TBL] [Abstract][Full Text] [Related]
38. Neuropeptides in migraine and cluster headache.
Edvinsson L; Goadsby PJ
Cephalalgia; 1994 Oct; 14(5):320-7. PubMed ID: 7828188
[TBL] [Abstract][Full Text] [Related]
39. Calcitonin Gene-Related Peptide Modulators - The History and Renaissance of a New Migraine Drug Class.
Hargreaves R; Olesen J
Headache; 2019 Jun; 59(6):951-970. PubMed ID: 31020659
[TBL] [Abstract][Full Text] [Related]
40. Calcitonin gene-related peptide and its role in migraine pathophysiology.
Arulmani U; Maassenvandenbrink A; Villalón CM; Saxena PR
Eur J Pharmacol; 2004 Oct; 500(1-3):315-30. PubMed ID: 15464043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
